WithdrawnPhase 2NCT04299503

Topical Crisaborole in Patients with Alopecia Areata

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Tufts Medical Center
Principal Investigator
David Rosmarin, MD
Tufts Medical Center
Intervention
Crisaborole Topical Ointment(drug)
Eligibility
2 years · All sexes
Timeline
20202022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04299503 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials